Director/PDMR Shareholding
Updated : 11:30
IntegraFin Holdings plc
PDMR dealings
IntegraFin Holdings plc announces that it has received the following notification of dealing in restricted securities from a person closely associated with a PDMR, with no change of beneficial ownership. The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Edward Gunby
| ||||
2. | Reason for the notification
| |||||
a) | Position/status | A person closely associated with a PDMR: Jonathan Gunby, Chief Development Officer | ||||
b) | Initial notification/Amendment | Initial | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a) | Name | IntegraFin Holdings plc
| ||||
b) | LEI | 213800CYIZKXK9PQYE87
| ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of £0.01 each
ISIN GB00BD45SH49 | ||||
b) | Nature of the transaction | A disposal to, and a transaction executed by, a person professionally arranging transactions on behalf of a person closely associated with a PDMR, with no change of beneficial ownership | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
| N/A | ||||
e) | Date of the transaction | 13 December 2018 | ||||
f) | Place of the transaction | Outside of trading venue |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.